The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(1-(4-Fluorobenzyl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)-N-(pyridin-3-ylmethyl)-1H-pyrazole-5-carboxamide ID: ALA3394697
Max Phase: Preclinical
Molecular Formula: C19H16FN7O2
Molecular Weight: 393.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1cccnc1)c1cc(-n2cnn(Cc3ccc(F)cc3)c2=O)n[nH]1
Standard InChI: InChI=1S/C19H16FN7O2/c20-15-5-3-13(4-6-15)11-27-19(29)26(12-23-27)17-8-16(24-25-17)18(28)22-10-14-2-1-7-21-9-14/h1-9,12H,10-11H2,(H,22,28)(H,24,25)
Standard InChI Key: FAIXKYSRYKWWGK-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
2.6746 6.1134 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1332 7.5416 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6332 7.5469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1017 6.1219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9336 3.1588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5972 1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4179 10.9883 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5621 10.0184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9932 8.6304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5111 8.7640 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1418 10.1998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0287 10.6480 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5330 12.4821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8861 13.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0035 14.6268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3573 15.2729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5937 14.4236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4763 12.9282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1226 12.2821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6766 14.9404 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
1 5 1 0
6 7 2 0
6 8 1 0
5 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
9 11 1 0
8 9 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
16 20 1 0
20 21 2 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
23 28 2 0
26 29 1 0
16 22 1 0
3 19 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.38Molecular Weight (Monoisotopic): 393.1350AlogP: 1.27#Rotatable Bonds: 6Polar Surface Area: 110.49Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.28CX Basic pKa: 4.82CX LogP: 1.76CX LogD: 1.76Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -2.07
References 1. Sun S, Zhang Z, Pokrovskaia N, Chowdhury S, Jia Q, Chang E, Khakh K, Kwan R, McLaren DG, Radomski CC, Ratkay LG, Fu J, Dales NA, Winther MD.. (2015) Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors., 23 (3): [PMID:25555732 ] [10.1016/j.bmc.2014.12.014 ]